SCHEMBL24933344

SCHEMBL24933344

CC(=O)Nc1cccc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 4/20 0.48
SIRT3 Q9NTG7 3/20 0.48
DHODH Q02127 1/20 0.47
MAOB P27338 3/20 0.44
SIRT1 Q96EB6 2/20 0.44
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FYN P06241 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30240716 1.00 SIRT2 (0.48) SIRT2SIRT3DHODHMAOBSIRT1
SCHEMBL24933661 0.89 MAOB (0.42) SIRT2SIRT3DHODHMAOBSIRT1
SCHEMBL24933346 0.88 MAOB (0.41) MAOBNPC1RAB9A
SCHEMBL30240693 0.88 MAOB (0.41) MAOBNPC1RAB9A
SCHEMBL24933199 0.85 MAOB (0.46) MAOBNPC1RAB9A
SCHEMBL30896275 0.85 LMNA (0.45) SIRT2DHODHSIRT1NPC1RAB9A
SCHEMBL30240807 0.85 MAOB (0.46) MAOBNPC1RAB9A
SCHEMBL24933362 0.85 MAOB (0.47) MAOBMAPTL3MBTL1
SCHEMBL24933615 0.85 MAOB (0.60) MAOBMAPTL3MBTL1
SCHEMBL24932976 0.85 MAOB (0.52) MAOBNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed